The wild-type sequence (wt) p5325–35 peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function …
D Ito, A Albers, YX Zhao, C Visus, E Appella… - The Journal of …, 2006 - journals.aai.org
Tumor peptide-based vaccines are more effective when they include tumor-specific Th cell-
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
The wild-type sequence (wt) p53 (25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function …
D Ito, A Albers, YX Zhao, C Visus… - Journal of …, 2006 - pubmed.ncbi.nlm.nih.gov
Tumor peptide-based vaccines are more effective when they include tumor-specific Th cell-
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
The wild-type sequence (wt) p53 (25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function …
D Ito, A Albers, YX Zhao, C Visus, E Appella… - … (Baltimore, Md.: 1950 …, 2006 - europepmc.org
Tumor peptide-based vaccines are more effective when they include tumor-specific Th cell-
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
The Wild-Type Sequence (wt) p5325–35 Peptide Induces HLA-DR7 and HLA-DR11-Restricted CD4+ Th Cells Capable of Enhancing the Ex Vivo Expansion and …
D Ito, A Albers, YX Zhao, C Visus, E Appella… - The Journal of …, 2006 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Tumor peptide-based vaccines are more
effective when they include tumor-specific Th cell-defined as well as CTL-defined peptides …
effective when they include tumor-specific Th cell-defined as well as CTL-defined peptides …
[PDF][PDF] The Wild-Type Sequence (wt) p5325–35 Peptide Induces HLA-DR7 and HLA-DR11-Restricted CD4 Th Cells Capable of Enhancing the Ex Vivo Expansion and …
D Ito, A Albers, YX Zhao, C Visus, E Appella… - 2006 - academia.edu
Tumor peptide-based vaccines are more effective when they include tumor-specific Th cell-
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
[PDF][PDF] The Wild-Type Sequence (wt) p5325–35 Peptide Induces HLA-DR7 and HLA-DR11-Restricted CD4 Th Cells Capable of Enhancing the Ex Vivo Expansion and …
D Ito, A Albers, YX Zhao, C Visus, E Appella… - 2006 - researchgate.net
Tumor peptide-based vaccines are more effective when they include tumor-specific Th cell-
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
The Wild-Type Sequence (wt) p5325–35 Peptide Induces HLA-DR7 and HLA-DR11-Restricted CD4+ Th Cells Capable of Enhancing the Ex Vivo Expansion and …
D Ito, A Albers, YX Zhao, C Visus, E Appella… - The Journal of …, 2006 - journals.aai.org
Tumor peptide-based vaccines are more effective when they include tumor-specific Th cell-
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
defined as well as CTL-defined peptides. Presently, two overlapping wild-type sequences …
[引用][C] The wild-type sequence (wt) p53 (25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4^+ Th cells capable of enhancing the ex vivo expansion and …
D ITO - J Immunol, 2006 - cir.nii.ac.jp
The wild-type sequence (wt) p53 (25-35) peptide induces HLA-DR7 and HLA-DR11-restricted
CD4^+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53 (264-272) …
CD4^+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53 (264-272) …